Literature DB >> 8961052

Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts.

Y W Miller1, E A Eady, R W Lacey, J H Cove, D N Joanes, W J Cunliffe.   

Abstract

The selection of a predominantly resistant staphylococcal skin flora in acne patients during antibiotic treatment has been extensively documented. This study sought to determine whether antibiotic therapy for acne had any effect on skin carriage of resistant coagulase-negative staphylococci (CNS) by close contacts of treated patients. Bacterial samples were obtained using a scrub wash technique from facial skin of 41 contacts (parents, siblings or partners) of patients who had been treated with at least three different antibiotics over a minimum period of 2 years. Samples were also obtained from 41 control subjects who had no known contact with any antibiotic treated acne patient. None of the contacts or controls had received any antibiotic therapy in the preceding two years. The number, percentage and prevalence of CNS resistant to each of seven antibiotics was estimated by plating serial ten-fold dilutions of wash fluid directly onto antibiotic-containing and antibiotic-free medium. Significantly more contacts than controls carried strains resistant to erythromycin, clindamycin, fusidic acid, trimethoprim and chloramphenicol as well as more multiply resistant strains (P < 0.05, chi 2). The number and percentage of staphylococci resistant to tetracycline, erythromycin, clindamycin, fusidic acid and chloramphenicol were also significantly raised (P < 0.05, Mann-Whitney U-test) in contacts. Only aminoglycoside resistance was not increased by any of the above criteria. These observations provide evidence that sequential antibiotic therapy for acne exerts selective pressure for increased skin carriage of resistant CNS not only in patients but also in their close contacts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961052     DOI: 10.1093/jac/38.5.829

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  18 in total

1.  Impact of Antibiotic Resistance on the Treatment of Gram-negative Sepsis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  [Do sulfonamides still retain a place in dermatological therapy?].

Authors:  A Schnuch
Journal:  Hautarzt       Date:  2002-03       Impact factor: 0.751

3.  Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community.

Authors:  F Coronado; J A Nicholas; B J Wallace; D J Kohlerschmidt; K Musser; D J Schoonmaker-Bopp; S M Zimmerman; A R Boller; D B Jernigan; M A Kacica
Journal:  Epidemiol Infect       Date:  2006-07-26       Impact factor: 2.451

Review 4.  Management of acne.

Authors:  John Kraft; Anatoli Freiman
Journal:  CMAJ       Date:  2011-02-28       Impact factor: 8.262

5.  Stemming the tide of antimicrobial resistance: implications for management of acne vulgaris.

Authors:  Miriam Santer; Nick A Francis; Duncan Platt; Elizabeth Anne Eady; Alison M Layton
Journal:  Br J Gen Pract       Date:  2018-02       Impact factor: 5.386

Review 6.  Reducing antibiotics for respiratory tract symptoms in primary care: consolidating 'why' and considering 'how'.

Authors:  C C Butler; S Rollnick; P Kinnersley; A Jones; N Stott
Journal:  Br J Gen Pract       Date:  1998-12       Impact factor: 5.386

7.  Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Authors:  Whitney P Bowe; Jennifer C Filip; Joseph M DiRienzo; Alla Volgina; David J Margolis
Journal:  J Drugs Dermatol       Date:  2006-10       Impact factor: 2.114

8.  Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics.

Authors:  Jay-Hyun Jo; Catriona P Harkins; Nicole H Schwardt; Jessica A Portillo; Matthew D Zimmerman; Claire L Carter; Md Amir Hossen; Cody J Peer; Eric C Polley; Véronique Dartois; William D Figg; Niki M Moutsopoulos; Julia A Segre; Heidi H Kong
Journal:  Sci Transl Med       Date:  2021-12-22       Impact factor: 17.956

9.  Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.

Authors:  E Batard; M-A Vibet; S Thibaut; S Corvec; J Pivette; D Lepelletier; J Caillon; E Montassier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-26       Impact factor: 3.267

10.  Could public restrooms be an environment for bacterial resistomes?

Authors:  Hermine V Mkrtchyan; Charlotte A Russell; Nan Wang; Ronald R Cutler
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.